Targeting B7-H3 in prostate cancer: Preclinical proof of concept with MGC018, an investigational anti-B7-H3 antibody-drug conjugate

被引：0
|
作者：
Scribner, Juniper A. [1 ]
Chen, Francine Z. [1 ]
De Costa, Anushka [1 ]
Li, Ying [1 ]
Chiechi, Michael [1 ]
Son, Thomas [1 ]
Hooley, Jeff [1 ]
Li, Jonathan [1 ]
Koenig, Scott [2 ]
Bohac, Chet [2 ]
Bonvini, Ezio [2 ]
Moore, Paul A. [2 ]
Loo, Deryk [1 ]
机构：
[1] MacroGenics Inc, Brisbane, CA USA
[2] MacroGenics Inc, Rockville, MD USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
330
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting B7-H3 in squamous cell carcinoma of the head and neck: Preclinical proof-of-concept with the investigational anti-B7-H3 antibody-drug conjugate, MGC018.
    Scribner, Juniper A.
    Chen, Francine Z.
    Li, Ying
    Chiechi, Michael
    Son, Thomas
    Hooley, Jeff
    Koenig, Scott
    Moore, Paul A.
    Bonvini, Ezio
    Bohac, Chet
    Loo, Deryk
    CANCER RESEARCH, 2021, 81 (13)
  • [2] Preclinical development of MGC018, a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer
    Scribner, Juniper A.
    Brown, Jennifer G.
    Sharma, Sharad
    Li, Hua
    Chiechi, Michael
    Li, Pam
    Son, Thomas
    De Costa, Anushka
    Chen, Yan
    Chen, Francine
    Barat, Bhaswati
    Huang, Ling
    Wolff, Christina
    Hooley, Jeff
    Hotaling, Tim E.
    Gaynutdinov, Timur
    Ciccarone, Valentina
    Tamura, James
    Koenig, Scott
    Johnson, Syd
    Moore, Paul A.
    Bonvini, Ezio
    Loo, Deryk
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer
    Scribner, Juniper A.
    Brown, Jennifer G.
    Son, Thomas
    Chiechi, Michael
    Li, Pam
    Sharma, Sharad
    Li, Hua
    De Costa, Anushka
    Li, Ying
    Chen, Yan
    Easton, Ann
    Yee-Toy, Nicholas C.
    Chen, Francine Z.
    Gorlatov, Sergey
    Barat, Bhaswati
    Huang, Ling
    Wolff, Christina R.
    Hooley, Jeff
    Hotaling, Tim E.
    Gaynutdinov, Timur
    Ciccarone, Valentina
    Tamura, James
    Koenig, Scott
    Moore, Paul A.
    Bonvini, Ezio
    Loo, Deryk
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (11) : 2235 - 2244
  • [4] Testing of B7-H3 targeting antibody-drug conjugate (ADC) MGC018 in models of pediatric solid tumors by the Pediatric Preclinical Testing Consortium (PPTC).
    Kurmasheva, Raushan
    Mosse, Yael P.
    Del Pozo, Vanessa
    Earley, Eric J.
    Erickson, Stephen W.
    Groff, David
    Kolb, E. Anders
    Krytska, Kateryna
    Smith, Malcolm A.
    Tsang, Matthew
    Teicher, Beverly A.
    Gorlick, Richard Greg
    Maris, John M.
    Houghton, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Anti-tumor activity of vobramitamab duocarmazine (MGC018), an investigational duocarmycin-based anti-B7-H3 antibody- drug conjugate (ADC), in preclinical neuroblastoma models
    Brignole, Chiara
    Bensa, Veronica
    Calarco, Enzo
    Giusto, Elena
    Ciampi, Eleonora
    Perri, Patrizia
    Corrias, Maria Valeria
    Astigiano, Simonetta
    Cilli, Michele
    Loo, Deryk
    Bonvini, Ezio
    Pastorino, Fabio
    Ponzoni, Mirco
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Phase 1 dose escalation study of MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors.
    Jang, Sekwon
    Powderly, John D.
    Spira, Alexander I.
    Bakkacha, Ouiam
    Loo, Deryk
    Bohac, Gerry C.
    Sharma, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: Preliminary results of phase I cohort expansion
    Shenderov, E.
    Mallesara, G. H. G.
    Wysocki, P. J.
    Xu, W.
    Ramlau, R.
    Weickhardt, A. J.
    Zolnierek, J.
    Spira, A.
    Joshua, A. M.
    Powderly, J.
    Antonarakis, E. S.
    Jang, S.
    Aragon-Ching, J.
    Shen, J.
    Paller, C.
    Vogelzang, N. J.
    Leu, K.
    Cortes, J.
    Bohac, C.
    Lugowska, I.
    ANNALS OF ONCOLOGY, 2021, 32 : S657 - U246
  • [8] MGC018, a duocarmycin-based antibody-drug conjugate targeting B7-H3, exhibits immunomodulatory activity and enhanced antitumor activity in combination with checkpoint inhibitors
    Scribner, Juniper A.
    Chiechi, Michael
    Li, Pam
    Son, Thomas
    Hooley, Jeff
    Li, Ying
    De Costa, Anushka
    Lung, Peter
    Yee-Toy, Nicholas
    Chen, Francine
    Barat, Bhaswati
    Wolff, Christina
    Ciccarone, Valentina
    Tamura, James
    Koenig, Scott
    Bohac, Chet
    Wigginton, Jon
    Moore, Paul A.
    Bonvini, Ezio
    Loo, Deryk
    CANCER RESEARCH, 2020, 80 (16)
  • [9] Preclinical development of a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer
    Son, Thomas
    Scribner, Juniper A.
    Hooley, Jeff
    Chiechi, Michael
    Li, Pam
    Hotaling, Timothy E.
    De Costa, Anushka
    Chen, Yan
    Chen, Francine
    Barat, Bhaswati
    Ciccarone, Valentina
    Gaynutdinov, Timur
    Tamura, James
    Koenig, Scott
    Johnson, Syd
    Moore, Paul A.
    Bonvini, Ezio
    Loo, Deryk
    CANCER RESEARCH, 2017, 77
  • [10] Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma
    Brignole, Chiara
    Calarco, Enzo
    Bensa, Veronica
    Giusto, Elena
    Perri, Patrizia
    Ciampi, Eleonora
    Corrias, Maria Valeria
    Astigiano, Simonetta
    Cilli, Michele
    Loo, Derik
    Bonvini, Ezio
    Pastorino, Fabio
    Ponzoni, Mirco
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
12345